Objective To observe the different effect of Xuezhikang Capsule on the patients of coronary heart disease （CHD） with abnormal blood lipid in different syndromes.Methods Of the 116 patients of CHD with abnormal blood lipid diagnosed by coronary arteriography and blood test

30 were blood stasis syndrome

23 phlegm turbid syndrome

26 phlegm retention syndrome

and 37 non-phlegm non-stasis syndrome. Based on the standard treatment with modern medicine

Xuezhikang Capsule was given 0.6g each time

twice a day

for 24 weeks in succession.Results After the treatment

total cholesterol （TC）

triglyceride （TG） and low density lipoprotein-C （LDL-C） were decreased （P<0.05）

and high density lipoprotein-C （HDL-C） was increased （P<0.05） in all patients. In the phlegm turbid group

the effect of TG decrease was superior to that of the non-phlegm non-stasis group （P<0.01）. In the phlegm retention group

the effect of HDL-C increase was better than that of the non-phlegm non-stasis group （P<0.05）.Conclusion Xuezhikang Capsule has a good regulation for blood lipid for all the CHD patients with abnormal blood lipid in different syndromes. The effect of TG decrease in the phlegm turbid group and HDL-C increase of in the phlegm retention group was superior to that of the non-phlegm non-stasis group.